Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIDCAB for Foot Surgery
NCT05368012Phase 4Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Jul 2022
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, dexamethasone in postoperative pain, sponsored by Hospital for Special Surgery. Started Jul 2022; status: completed.
02
Drugs
bupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05368012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05368012.